|Day's Range||33.71 - 33.99|
|52 Week Range||25.55 - 35.60|
|PE Ratio (TTM)||25.42|
|Dividend & Yield||1.90 (5.61%)|
|1y Target Est||N/A|
AstraZeneca’s (AZN) revenue is expected to fall 9.5% to $5.1 billion in 2Q17, compared to $5.6 billion in 2Q16.
GlaxoSmithKline's new chief executive announced plans on Wednesday to narrow the focus of the group's drug research by ditching more than 30 drug projects to improve returns in its core pharmaceuticals ...
AstraZeneca (AZN) is one of the largest pharmaceutical companies by revenue. The company operates in over 100 countries and deals with primary care and specialty care medicines.